Sonsalla P K, Nicklas W J, Heikkila R E
Department of Neurology, University of Medicine and Dentistry of New Jersey--Robert Wood Johnson Medical School, Piscataway 08854.
Science. 1989 Jan 20;243(4889):398-400. doi: 10.1126/science.2563176.
The systemic administration of either methamphetamine or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to experimental animals produces degenerative changes in nigrostriatal dopaminergic neurons or their axon terminals. This study was conducted to determine if excitatory amino acids, which appear to be involved in various neurodegenerative disorders, might also contribute to the dopaminergic neurotoxicity produced in mice by either methamphetamine or MPTP. MK-801, phencyclidine, and ketamine, noncompetitive antagonists of one subtype of excitatory amino acid receptor, the N-methyl-D-aspartate receptor, provided substantial protection against neurotoxicity produced by methamphetamine but not that produced by MPTP. These findings indicate that excitatory amino acids play an important role in the nigrostriatal dopaminergic damage induced by methamphetamine.
向实验动物全身给药甲基苯丙胺或1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)会导致黑质纹状体多巴胺能神经元或其轴突终末发生退行性变化。本研究旨在确定似乎与各种神经退行性疾病有关的兴奋性氨基酸是否也可能导致甲基苯丙胺或MPTP对小鼠产生的多巴胺能神经毒性。MK-801、苯环利定和氯胺酮是兴奋性氨基酸受体的一种亚型(N-甲基-D-天冬氨酸受体)的非竞争性拮抗剂,它们对甲基苯丙胺产生的神经毒性提供了实质性保护,但对MPTP产生的神经毒性没有保护作用。这些发现表明,兴奋性氨基酸在甲基苯丙胺诱导的黑质纹状体多巴胺能损伤中起重要作用。